In addition to decreased fat mass, Kim et al. showed that global ablation or pharmacologic inhibition of sclerostin led to improved insulin sensitivity and protection from diet-induced obesity that was associated with the “beiging” of peripheral WAT [13]. The gene discussed is SOST; the disease is obesity disorder.